Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma

Modern Pathology

Volumn 21, Issue 12, 2008, Pages 1444-1450

  Chuang, Hui Ching ^a   Su, Chih Ying ^a,b   Huang, Hsuang Ying ^a   Huang, Chao Cheng ^a   Chien, Chih Yen ^a   Du, Yung Ying ^a   Chuang, Jiin Haur ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Buccal squamous cell carcinoma; Immunohistochemistry; MMP 7 (matrilysin 1); Western blotting

Indexed keywords

MATRILYSIN;

ADULT; AGED; ARTICLE; BONE; BUCCAL SQUAMOUS CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR VOLUME; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CHEEK; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 56649106468     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.99     Document Type: Article

References (42)

1. Cancer Registry. Department of Health, Executive Yuan, Taiwan, Republic of China, 2006.
2. Chen YK, Huang HC, Lin LM, et al. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999;35:173-179.
3. Jones AS, England J, Hamilton J, et al. Mandibular invasion in patiens with oral and oropharyngeal squamous cell carcinoma. Clin Otolaryngol Allied Sci 1997;22:239-245.
4. Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer. Oral Oncol 1999;35:227-233.
5. Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head Neck 2006;28:639-648.
6. Sutinen M, Kainulainen T, Hurskainen T, et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 1998;77:2239-2245.
7. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999;21:627-638.
8. Franchi A, Santucci M, Masini E, et al. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 2002;95:1902-1910.
9. Lin SC, Lo SS, Liu CJ, et al. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 2004;33:405-409.
10. O-Charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol 2006;42:257-267.
11. de Vicente JC, Fresno MF, Villalain L, et al. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 2005;41:283-293.
12. Liu WW, Zeng ZY, Wu QL, et al. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngol Head Neck Surg 2005;132:395-400.
13. Patel BP, Shah PM, Rawal UM, et al. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 2005;90:81-88.
14. de Vicente JC, Fresno MF, Villalain L, et al. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma. Oral Oncol 2005;41:568-579.
15. Ii M, Yamamoto H, Adachi Y, et al. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006;231:20-27.
16. Polette M, Nawrocki-Raby B, Gilles C, et al. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 2004;49:179-186.
17. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174.
18. Weber A, Hengge UR, Stricker I, et al. Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum Pathol 2007;38:228-238.
19. O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127:813-820.
20. Xie M, Sun Y, Li Y. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope 2004;114:2243-2248.
21. Impola U, Uitto VJ, Hietanen J, et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004;202:14-22.
22. de Vicente JC, Lequerica-Fernandez P, Santamaria J, et al. Expression of MMP-7 and MT-1 MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J Oral Pathol Med 2007;36:415-424.
23. Vairaktairs E, Serefoglou Z, Yapijakis C, et al. High gene expression of matrix metalloproteinase-7 is associated with early stage of oral cancer. Anticancer Res 2007;27:2493-2498.
24. Liao CT, Wang HM, Ng SH, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol 2006;42:800-809.
25. Lo WL, Kao SY, Chi LY, et al. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 2003;61:751-758.
26. Katayama A, Bandoh N, Kishibe K, et al. Expression of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastasis and prognosis. Clin Cancer Res 2004;10:634-640.
27. Pyo SW, Hashimoto M, Kim YS, et al. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 2007;35:1-9.
28. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996;28:123-136.
29. Hemers E, Duval C, McCaig C, et al. Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling. Cancer Res 2005;65:7363-7369.
30. Witty JP, McDonnell S, Newell KJ, et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994;54:4805-4812.
31. Hasegawa S, Koshikawa N, Momiyama N, et al. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int J Cancer 1998;76:812-816.
32. Leeman MF, Curran S, Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003;201:528-534.
33. Adachi Y, Yamamoto H, Itoh F, et al. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 1999;45:252-258.
34. Zhang J, Jin X, Fang S, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005;26:1748-1753.
35. McCaig C, Duval C, Hemers E, et al. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. Gastroenterology 2006;130:1754-1763.
36. Liu XP, Kawauchi S, Oga A, et al. Prognostic significance of matrix metallo proteinase-7 (MMP-7) expression at the invasion front in gastric carcinoma. Jpn J Cancer Res 2002;93:291-295.
37. Jones LE, Humphreys MJ, Campbell FC, et al. Comprehensive analysis of maxtrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004;10:2832-2845.
38. Wang F, Reierstad S, Fishman DA. Matrilysin overexpression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett 2006;236:292-301.
39. Lynch CC, Hikosaka A, Acuff HB, et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 2005;7:485-496.
40. Wang F, So J, Reierstad S, et al. Matrilysin(MMP-7) promotes invasion of ovarian cells by activation of progelatinase. Int J Cancer 2005;114:19-31.
41. Sillanpaa SM, Anttila MA, Voutilainen KA, et al. Prognostic significance of matrix metalloproteinases-7 in epithelial ovarian cancer and its relation to β-catenin expression. Int J Cancer 2006;119:1792-1799.
42. Leinonen T, Prinen R, Bohm J, et al. Expression of matrix metalloproteinase 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, β-catenin and prognosis. Lung Cancer 2006;51:313-321.